Class III Medical Device Designation by MFDS

MDD Digital Therapeutics
BlueKare MFDS Certificated

Learn More
0+
Digital Healthcare Solutions
0+
Hospital Partners
0K+
Cumulative Users
0
MDFS Approved
What We Do

Featured Solutions

Solving mental health challenges with evidence-based digital therapeutics

AttnKare-D

AttnKare-D

A digital therapeutic device that precisely diagnoses ADHD using VR and AI technology.

Digital TherapeuticsADHDDiagnosisMFDS Approval In Progress
BlueKare

BlueKare

Manage and treat depression in daily life with CBT-based programs and real-time AI analysis.

Digital TherapeuticsDepressionTreatmentMFDS ApprovedInnovative Medical Device
WithBuddy

WithBuddy

An AI buddy care service that eases daily stress through meditation, breathing, and conversation programs.

HealthcareDaily CareMood ReliefCBT
View All Solutions
Latest

News

Press Release June 17, 2025

Sang-Ho Lee of Hippo T&C Selected for Oral Presentation at AAAI 2025

#AAAI
Press Release June 16, 2025

Hippo T&C’s ‘BlueKare’ Becomes the First Depression Digital Therapeutic Approved by the Ministry of Food and Drug Safety in Korea

#BlueKare#MFDS#MDD
Notice June 17, 2025

Sang-Ho Lee of Hippo T&C Selected for Oral Presentation at AAAI 2025

#AAAI
Notice July 2, 2024

Hippo T&C Meets with UNMC Psychiatry Professors to Discuss Collaboration

#UNMC#Hippo T&C#Collaboration
View All

Looking for partners to build the future of digital therapeutics together

We welcome collaboration with hospitals, companies, and research institutions

All Partnerships Contact Us